References
- Boquist, L., Boquist, S., Ericsson, I. (1988). Structural beta-cell changes and transient hyperglycemia in mice treated with compounds inducing inhibited citric acid cycle enzyme activity. Diabetes 37:89–98.
- Bosakowski, T., Levin, A. A. (1986). Serum citrate as a peripheral indicator of fluoroacetate and fluorocitrate toxicity in rats and dogs. Toxicol Appl Pharmacol 85:428–436.
- Bowman, R. H. (1964). Inhibition of citrate metabolism by sodium fluoroacetate in the perfused rat heart and the effect on phosphofructokinase activity and glucose utilization. Biochem J 93:13c–15c.
- Chenoweth, M. B. (1949). Monofluoroacetic acid and related compounds. J Pharmacol Exp Ther 97:383–424.
- Cheung, P. Y., Danial, H., Jong, J., Schulz, R. (1998). Thiols protect the inhibition of myocardial aconitase by peroxynitrite. Arch Biochem Biophys 350:104–108.
- Eason, C. (2002). Sodium monofluoroacetate (1080) risk assessment and risk communication. Toxicology 181–182:523–530.
- ERMA (Environmental Risk Management Authority). (2007). The reassessment of 1080. New Zealand: Available at: http://ermanz.govt.nz/news-events/1080/ERMA%201080%20Reassessment%20FINAL.pdf.
- Fonnum, F., Johnsen, A., Hassel, B. (1997). Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia 21:106–113.
- Fukushima, E., Seki, K., Norimoto, K. Okuchi, K. (2006). Rodenticide (monofluoroacetate) poisoning: a case report. Proceedings of the 28th Annual Meeting of the Japanese Society for Clinical Toxicology, July 7–8, 2006, Ehime, Japan. Tokyo, Japan: Herusu Shuppan.
- Goh, C. S., Hodgson, D. R., Fearnside, S. M., Heller, J., Malikides, N. (2005). Sodium monofluoroacetate (compound 1080) poisoning in dogs. Aust Vet J 83:474–479.
- Goncharov, N. V., Jenkins, R. O., Radilov, A. F. (2006). Toxicology of fluoroacetate: a review, with possible directions for therapy research. J Appl Toxicol 26:148–161.
- Gribble, G. W. (1973). Fluoroacetate toxicity. J Chem Educ 50:460–462.
- Holstege, C. P., Bechtel, L. K., Reilly, T. H., Wispelwey, B. P., Dobmeier, S. G. (2007). Unusual, but potential, agents of terrorists. Emerg Med Clin North Am 25:549–566.
- Matsuura, F., Inuma, Y., Hirose, K., Miyajima, Y., Tanaka, T., Kumatani, T., et al. (2006). Acute renal failure caused by monofluoroacetate (Fratol): a case report. Proceedings of the 26th Annual Meeting of the Japanese Society for Clinical Toxicology, July 9–10, 2004, Hiroshima, Japan. Tokyo, Japan: Herusu Shuppan.
- McGarry, J. D., Foster, D. W. (1980). Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49:395–420.
- Mehlman, M. A. (1968). Inhibition of pyruvate carboxylation by fluorocitrate in rat kidney mitochondria. J. Biol. Chem. 243:1919–1925.
- NIOSH (The National Institute for Occupational Safety and Health). (2006). RTECS(R) CD-Rom Issue 96(2). Atlanta, Georgia, USA: Centers for Disease Control and Prevention.
- Norris, W. R. (2001). Sodium fluoroacetate. IPCSINTOX Databank, Poison Information Monograph 494. Available at: http://www.intox.org/databank/documents/chemical/sodfluor/pim494.htm. May 4, 2009.
- Pattison, F. L. M. (1959). Toxic aliphatic fluorine compounds. Br Med J 14:110.
- Peters, R. A. (1971). Some metabolic aspects of fluoroacetate, especially related to fluorocitrate. Ciba Found Symp 2:55–76.
- Proudfoot, A. T., Bradberry, S. M., Vale, J. A. (2006). Sodium fluoroacetate poisoning. Toxicol Rev 25:213–219.
- Stewart, G. G., Abbs, E. T., Roberts, D. J. (1970). Biochemical effects of FA administration in rat brain, heart, and blood. Biochem Pharmacol 19:1861–1866.
- Szerb, J. C., Redondo, I. M. (1993). Astrocytes and the entry of circulating ammonia into the brain: effect of fluoroacetate. Metab Brain Dis 8:217–234.
- Zhou, J. L., Kauffman, F. C., Ballow, C. H., Thurman, R. G. (1984). Inhibition of mixed-function oxidation in perfused rat liver by fluoroacetate treatment. Biochem Pharmacol 33:319–323.
- Zieve, L., Lyftogt, C., Draves, K. (1983). Toxicity of a fatty acid and ammonia: interactions with hypoglycemia and Krebs cycle inhibition. J Lab Clin Med 101:930–939.